Literature DB >> 6254060

Origin and functional properties of the major gene product of the Snyder-Theilen strain of feline sarcoma virus.

M Barbacid, K Beemon, S G Devare.   

Abstract

The only known product of the Snyder-Theilen strain of feline sarcoma virus (ST-FeSV) is a 85,000-dalton protein, designated ST P85, that contains feline leukemia virus gag gene encoded proteins (p15, p12, and a fragment of p30) and a sarcoma virus-specific polypeptide. Antibodies directed against the latter immunoprecipitated a 92,000-dalton phosphoprotein (NCP 92) expressed at low levels in normal feline embryo fibroblasts as well as in feline cells of epithelial or lymphoid origin. Normal cellular proteins crossreactive with ST P85 were also detected in cell lines from various other mammalian species. These results suggest that the ST-FeSV sequences encoding for the sarcoma virus-specific domain of ST P85 originated from an evolutionarily conserved cellular gene expressed in cells of independent differentiation lineage. Immunoprecipitates containing ST-FeSV P85 exhibited a protein kinase activity that specifically phosphorylated tyrosine residues. The physiological significance of this finding is illustrated by the finding that phosphotyrosine is an intrinsic component of ST P85. Furthermore, 5- to-fold higher levels of this unusual phosphorylated amino acid were present in ST-FeSV transformants than in uninfected control cells. Phosphorylation of tyrosine residues appears to be associated with cellular transformation caused by Rous sarcoma virus and Abelson murine leukemia virus. Thus, independent transforming virus isolates from birds, mice, and cats may utilize common pathways in exerting their oncogenic potential.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254060      PMCID: PMC350016          DOI: 10.1073/pnas.77.9.5158

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Differences between the ribonucleic acids of transforming and nontransforming avian tumor viruses.

Authors:  P H Duesberg; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1970-12       Impact factor: 11.205

2.  Development and characterization of cell lines from subhuman primates.

Authors:  R E Wallace; P J Vasington; J C Petricciani; H E Hopps; D E Lorenz; Z Kadanka
Journal:  In Vitro       Date:  1973 Mar-Apr

3.  Spontaneous feline fibrosarcomas: transmissibility and ultrastructure of associated virus-like particles.

Authors:  S P Snyder
Journal:  J Natl Cancer Inst       Date:  1971-11       Impact factor: 13.506

4.  Experimental transmission of feline fibrosarcoma to cats and dogs.

Authors:  M B Gardner; R W Rongey; P Arnstein; J D Estes; P Sarma; R J Huebner; C G Rickard
Journal:  Nature       Date:  1970-05-30       Impact factor: 49.962

5.  Transmissible feline fibrosarcoma.

Authors:  S P Snyder; G H Theilen
Journal:  Nature       Date:  1969-03-15       Impact factor: 49.962

6.  Replication of cat leukemia virus in cell suspension cultures.

Authors:  G H Theilen; T G Kawakami; J D Rush; R J Munn
Journal:  Nature       Date:  1969-05-10       Impact factor: 49.962

7.  A transmissible feline fibrosarcoma of viral origin.

Authors:  S K McDonough; S Larsen; R S Brodey; N D Stock; W D Hardy
Journal:  Cancer Res       Date:  1971-07       Impact factor: 12.701

8.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

Authors:  D J Giard; S A Aaronson; G J Todaro; P Arnstein; J H Kersey; H Dosik; W P Parks
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

9.  Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells.

Authors:  J L Jainchill; S A Aaronson; G J Todaro
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

10.  Persistent infection of a rat kidney cell line with Rauscher murine leukemia virus.

Authors:  E N Rosenblum; R F Zeigel
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

View more
  57 in total

1.  Development and characterization of a panel of monoclonal antibodies against the catalytic domain of the human fes proto-oncogene product.

Authors:  A van Bokhoven; H L van Duijnhoven; M Jücker; A J Roebroek; W J van de Ven
Journal:  Mol Biol Rep       Date:  1992-02       Impact factor: 2.316

2.  fur gene expression as a discriminating marker for small cell and nonsmall cell lung carcinomas.

Authors:  J A Schalken; A J Roebroek; P P Oomen; S S Wagenaar; F M Debruyne; H P Bloemers; W J Van de Ven
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

Review 3.  Treatment for chronic myelogenous leukemia: the long road to imatinib.

Authors:  Tony Hunter
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

4.  Two additional protein-tyrosine kinases expressed in human lung: fourth member of the fibroblast growth factor receptor family and an intracellular protein-tyrosine kinase.

Authors:  U Holtrich; A Bräuninger; K Strebhardt; H Rübsamen-Waigmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 5.  Phosphotyrosyl protein phosphatases.

Authors:  K H Lau; J R Farley; D J Baylink
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

6.  Mechanism of activation of the human trk oncogene.

Authors:  F Coulier; D Martin-Zanca; M Ernst; M Barbacid
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

7.  Frequent generation of oncogenes by in vitro recombination of TRK protooncogene sequences.

Authors:  R Oskam; F Coulier; M Ernst; D Martin-Zanca; M Barbacid
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

8.  Antibodies of predetermined specificity detect two retroviral oncogene products and inhibit their kinase activities.

Authors:  S Sen; R A Houghten; C J Sherr; A Sen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

9.  Amino acid alterations within a highly conserved region of the Rous sarcoma virus src gene product pp60src inactivate tyrosine protein kinase activity.

Authors:  D L Bryant; J T Parsons
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

10.  Four different classes of retroviruses induce phosphorylation of tyrosines present in similar cellular proteins.

Authors:  J A Cooper; T Hunter
Journal:  Mol Cell Biol       Date:  1981-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.